| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/25/2001 | US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294564 Benzimidazoles and benzoxazoles |
| 09/25/2001 | US6294561 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/25/2001 | US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/25/2001 | US6294555 1-[(1-Substituted-4-piperidinyl)methyl]-4-piperidine derivative, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| 09/25/2001 | US6294531 Calcilytic compounds |
| 09/25/2001 | US6294525 Reverse-turn mimetics and methods relating thereto |
| 09/25/2001 | US6294350 Methods for treating fibroproliferative diseases |
| 09/25/2001 | CA2214601C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/23/2001 | CA2341926A1 Oral formulations of medicaments |
| 09/20/2001 | WO2001068888A2 Production of chimeric capsid vectors |
| 09/20/2001 | WO2001068860A1 Antibodies to human cd154 |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068662A1 Method of preparing clarithromycin of form ii crystals |
| 09/20/2001 | WO2001068653A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents |
| 09/20/2001 | WO2001068652A1 Condensed imidazoles as histamine h3 receptor ligands |
| 09/20/2001 | WO2001068651A1 Condensed imidazoles as histamine h3 receptor ligands |
| 09/20/2001 | WO2001068643A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | WO2001068622A1 Novel cyclobutene derivatives useful as antagonists of the motilin receptor |
| 09/20/2001 | WO2001068621A1 Novel cyclohexene derivatives useful as antagonists of the motilin receptor |
| 09/20/2001 | WO2001068620A1 Novel cyclopentene derivatives useful as antagonists of the motilin receptor |
| 09/20/2001 | WO2001068603A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 09/20/2001 | WO2001068594A1 Method for oxidizing a thioether group into a sulfoxide group |
| 09/20/2001 | WO2001068591A1 Carboxylic acid derivatives as ip antagonists |
| 09/20/2001 | WO2001068582A1 Novel fatty acid analogous |
| 09/20/2001 | WO2001068570A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068569A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068568A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068186A2 Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 09/20/2001 | WO2001068144A2 Biodegradable immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | WO2001068135A2 Compositions and methods for affecting osteogenesis |
| 09/20/2001 | WO2001068112A2 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 09/20/2001 | WO2001068105A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 09/20/2001 | WO2001068084A1 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068078A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/20/2001 | WO2001068075A2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/20/2001 | WO2001068058A1 Multilayer pharmaceutical product for release in the colon |
| 09/20/2001 | WO2001068038A2 System for the controlled delivery of an active material to a dental site |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001034591A3 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/20/2001 | WO2001032180A3 Composition for treatment of constipation and irritable bowel syndrome |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001028579A3 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 09/20/2001 | WO2001019819A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/20/2001 | WO2001016603A3 Analysis and treatment of body weight and eating disorders |
| 09/20/2001 | WO2001015675A3 Use of docetaxel for treating hepatocellular carcinoma |
| 09/20/2001 | WO2000027378A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | US20010023257 Hypotensive agents; anticholesterol agents |
| 09/20/2001 | US20010023256 Reducing concentration of oxygen metabolites |
| 09/20/2001 | US20010023250 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 09/20/2001 | US20010022971 IBD-associated microbial nucleic acid molecules |
| 09/20/2001 | US20010022970 Halogenated xanthan compound |
| 09/20/2001 | US20010022969 Sepsis therapy |
| 09/20/2001 | US20010022964 Fast dissolving orally consumable films |
| 09/20/2001 | EP1143960A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | DE10013029A1 Multilayer formulation for controlled drug release in colon, comprising drug-containing core having inner and outer coatings of acrylic copolymers with quaternary ammonium and anionic groups respectively |
| 09/20/2001 | CA2403679A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2403393A1 Methods and compositions for immunoregulation |
| 09/20/2001 | CA2403063A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 09/20/2001 | CA2403062A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2402898A1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | CA2402891A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2402733A1 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 09/20/2001 | CA2402549A1 Substituted beta-carbolines |
| 09/20/2001 | CA2402427A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents |
| 09/20/2001 | CA2402413A1 Compositions and methods for affecting osteogenesis |
| 09/20/2001 | CA2402250A1 Immunomodulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/20/2001 | CA2400106A1 Antibodies to human cd154 |
| 09/20/2001 | CA2373110A1 Production of chimeric capsid vectors |
| 09/19/2001 | EP1134286A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/19/2001 | EP1134229A2 Method of preparing clarithromycin of form II crystals |
| 09/19/2001 | EP1134220A1 Benzoxazole derivatives and drugs containing the same as the active ingredient |
| 09/19/2001 | EP1134215A1 2-oxo-imidazolidine-4-carboxylic acid hydroxamine compounds that inhibit matrix metalloproteinases |
| 09/19/2001 | EP1133557A2 Growth factor modulators |
| 09/19/2001 | EP1133494A1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
| 09/19/2001 | EP1133488A1 Propanoic acid derivatives as integrin inhibitors |
| 09/19/2001 | EP1133487A1 Scavenger compounds |
| 09/19/2001 | EP1133486A2 Nonsteroidal antiinflammatories |
| 09/19/2001 | EP1133484A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 09/19/2001 | EP1133482A1 Il-5 inhibiting 6-azauracil derivatives |
| 09/19/2001 | EP1133481A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133474A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 09/19/2001 | EP1133471A1 Hydrazine derivatives |
| 09/19/2001 | EP1133467A1 Ion channel modulating agents |
| 09/19/2001 | EP1133315A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |
| 09/19/2001 | EP1133300A1 Desmethylolanzapine compositions and methods |
| 09/19/2001 | EP1133285A1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 09/19/2001 | EP1133284A1 New process |
| 09/19/2001 | EP1133278A2 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 09/19/2001 | EP1133273A1 Method for inhibiting dental resorptive lesions |
| 09/19/2001 | EP1112750A9 Drug composition for topical administration |
| 09/19/2001 | EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 09/19/2001 | EP0880522B1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES AMPA AND NMDA RECEPTORS ANTAGONISTS, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME |
| 09/19/2001 | EP0874849B1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives |
| 09/19/2001 | EP0871434B1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 09/19/2001 | EP0770077B1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 09/19/2001 | EP0697877B1 Psyllium drink mix compositions |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1313772A Peptide antagonists of zonulin and methods for use of same |